Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMP MODEL OF REGULATION SHOULD APPLY TO FDA's INTERNET OVERSIGHT, GLAXO EXEC SUGGESTS; "REASONABLE ACCESS" TO LABELING COULD BE STANDARD FOR FAIR BALANCE

Executive Summary

FDA should apply the flexible model embodied in its Good Manufacturing Practices regulation to assure fairness and accuracy on the Internet, Glaxo Wellcome Assistant General Counsel David Vance told FDA's Internet promotions meeting on Oct. 16.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029030

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel